United States
Securities and Exchange Commission
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF... (continue reading...)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 10-Q
☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended June 30, 2022
or
☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ______to______
Commission File Number 001-33997
KANDI TECHNOLOGIES GROUP, INC. (Exact... (continue reading...)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August, 2022.
Commission File Number 001-40733
LI-CYCLE HOLDINGS CORP.
Li-Cycle Holdings Corp.
207 Queen’s Quay West, Suite 590
Toronto, ON M5J 1A7
(877) 542-9253
Indicate by check mark whether the registrant files or will file annual... (continue reading...)
More SEC Filings
View Older Stories-
Form 10-Q MARTEN TRANSPORT LTD For: Jun 30
-
Form 8-K LENSAR, Inc. For: Aug 08
-
Form 8-K Party City Holdco Inc. For: Aug 08
-
Form 8-K DOMINION ENERGY, INC For: Aug 08
-
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 04 Filed by: Zaks Tal Zvi
-
Form 8-K Carlyle Group Inc. For: Aug 07
-
Form 13F-HR Central Asset Investment For: Jun 30
-
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 04 Filed by: Vergis Janet S.
-
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 04 Filed by: Satchi-Fainaro Ronit
-
Form 10-Q Energy Vault Holdings, For: Jun 30
-
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 04 Filed by: Peres Nechemia Jacob
-
Form SC 13G/A Avalo Therapeutics, Inc. Filed by: Caissa Capital Management ltd.
-
Form 8-K CinCor Pharma, Inc. For: Aug 08
-
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 04 Filed by: MIGNONE ROBERTO
-
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 04 Filed by: Nisen Perry
-
Form 4 LAKELAND FINANCIAL CORP For: Aug 05 Filed by: WELCH M SCOTT
-
Form 8-K W&T OFFSHORE INC For: Aug 08
-
Form 10-Q SVB FINANCIAL GROUP For: Jun 30
-
Form 10-Q ModivCare Inc For: Jun 30
-
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 04 Filed by: LIEBERMAN GERALD M
-
Form 6-K CERAGON NETWORKS LTD For: Aug 08
-
Form 10-Q MARKETWISE, INC. For: Jun 30
-
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 04 Filed by: Halfon Jean Michel
-
Form 10-Q PRECISION BIOSCIENCES For: Jun 30
-
Form 4 LAKELAND FINANCIAL CORP For: Aug 05 Filed by: Smith Brian J
-
Form 6-K BioNTech SE For: Jun 30
-
Form DEFA14A AVALARA, INC.
-
Form 10-Q CECO ENVIRONMENTAL CORP For: Jun 30
-
Form 10-Q TCR2 THERAPEUTICS INC. For: Jun 30
-
Form 8-K Kandi Technologies Group For: Aug 08
-
Form 10-Q CPI Card Group Inc. For: Jun 30
-
Form 6-K BioNTech SE For: Jun 30
-
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 04 Filed by: Elstein Amir
-
Form 13F-HR Triodos Investment Manag For: Jun 30
-
Form 8-K PRECISION BIOSCIENCES For: Aug 08
-
Form 497VPI NATIONWIDE VARIABLE ACCO
-
Form 10-Q BeiGene, Ltd. For: Jun 30
-
Form 425 Tailwind Acquisition Filed by: Tailwind Acquisition Corp.
-
Form 4 TEVA PHARMACEUTICAL INDU For: Aug 04 Filed by: Crane Rosemary A
-
Form 497 NATIONWIDE VARIABLE ACCO
-
Form 8-K AVALARA, INC. For: Aug 08
-
Form 4 LAKELAND FINANCIAL CORP For: Aug 05 Filed by: Augsburger Blake
-
Form D Silenok Funds, LP - B1
-
Form 8-K Vigil Neuroscience, Inc. For: Aug 08
-
Form 8-K CinCor Pharma, Inc. For: Aug 08
-
Form 6-K CERAGON NETWORKS LTD For: Aug 08
-
Form 8-K CECO ENVIRONMENTAL CORP For: Aug 08
-
Form 6-K IM Cannabis Corp. For: Aug 08
-
Form 8-K Tailwind Acquisition For: Aug 05
-
Form 8-K NEWS CORP For: Aug 05
